| Product Code: ETC7890219 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2023, Laos saw a significant increase in imports of gamma-aminobutyric acid (GABA) receptor agonists, with top exporters being Vietnam, China, Areas, nes, Australia, and Namibia. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, suggesting dominant players in the industry. With a remarkable compound annual growth rate (CAGR) of 58.92% and a growth rate of 15.15%, the demand for GABA receptor agonists in Laos is rapidly expanding, presenting lucrative opportunities for exporters and stakeholders in the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Overview |
3.1 Laos Country Macro Economic Indicators |
3.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Industry Life Cycle |
3.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Porter's Five Forces |
3.5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.7 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.8 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of anxiety disorders and other neurological conditions, leading to a higher demand for GABA receptor agonists. |
4.2.2 Growing awareness about the benefits of GABA receptor agonists in managing stress and improving mental well-being. |
4.2.3 Favorable regulatory environment supporting the development and commercialization of GABA receptor agonist drugs. |
4.3 Market Restraints |
4.3.1 Limited availability of GABA receptor agonist drugs in the market due to stringent regulatory approvals and complex manufacturing processes. |
4.3.2 Potential side effects and safety concerns associated with GABA receptor agonists, impacting patient acceptance and adoption. |
4.3.3 Competition from alternative therapies and medications for anxiety and neurological disorders. |
5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Trends |
6 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Types |
6.1 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Insomnia, 2021- 2031F |
6.1.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Epilepsy, 2021- 2031F |
6.1.5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Spasticity, 2021- 2031F |
6.1.6 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Anxiety, 2021- 2031F |
6.1.7 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Drugs |
6.2.1 Overview and Analysis |
6.2.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Zolpidem, 2021- 2031F |
6.2.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Topiramate, 2021- 2031F |
6.2.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.2.5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Therapeutics |
6.3.1 Overview and Analysis |
6.3.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Bamaluzole, 2021- 2031F |
6.3.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Phenibut, 2021- 2031F |
6.3.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Baclofen, 2021- 2031F |
6.3.5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Gaboxadol, 2021- 2031F |
6.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Intrathecal, 2021- 2031F |
6.4.5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
7 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Import-Export Trade Statistics |
7.1 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Export to Major Countries |
7.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Imports from Major Countries |
8 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Key Performance Indicators |
8.1 Patient adherence rates to GABA receptor agonist treatment plans. |
8.2 Number of clinical trials and research studies on new GABA receptor agonist compounds. |
8.3 Percentage of healthcare professionals recommending GABA receptor agonists as a treatment option. |
8.4 Rate of adoption of GABA receptor agonist drugs in different regions/markets. |
8.5 Patient-reported outcomes and satisfaction levels with GABA receptor agonist therapy. |
9 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Opportunity Assessment |
9.1 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.3 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.4 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market - Competitive Landscape |
10.1 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Laos Gamma-aminobutyric Acid (GABA) Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |